Newsroom

Ampersand Biosciences Receives SBIR Grant 2024

Ampersand Biosciences and Trudeau Institute have been awarded a $1,084,824 Phase II Small Business Innovative Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID).

Species: Ferret
Focus: Validation of Monoclonal Antibodies to Study Respiratory Infections in the Ferret

October 29, 2024/by Geoff Sanford

Ampersand Biosciences awarded SBIR Grant for Immunologic Analysis of Non-Mammalian and Underrpresented Mammalian Models

Ampersand Biosciences was awarded a contract by the National Institute of Allergy and Infectious Diseases (NIAID) on September 20, 2022 until Dece,ber 15, 2024 for immunologic analysis of non-mammalian and underrepresented mammalian models.

NAICS: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
PSC: AN12 - Health R&D Services; Health Care Services; Applied Research

September 30, 2024/by Geoff Sanford

Ampersand Biosciences awarded contract by NIAID for further characterization and validation of monoclonal antibodies to study respiratory

Ampersand Biosciences was awarded a contract by the National Institute of Allergy and Infectious Diseases (NIAID) on September 30, 2024 until September 29, 2026 to further characterize and validate monoclonal antibodies to study respiratory.

NAICS: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
PSC: AN12 - Health R&D Services; Health Care Services; Applied Research

September 30, 2024/by Geoff Sanford

Ampersand Biosciences participates in Touch a Truck Funraiser 2024

Ampersand Biosciences participated in the annual Touch a Truck Fundraiser in 2024 in Saranac Lake, NY.

September 17, 2024/by Geoff Sanford

Ampersand Biosciences Partners with Bioz

Ampersand Biosciences partners with the world's leading life science-focused AI company Bioz.

July 24, 2024/by Geoff Sanford

Block Symposium Tailoring the Immune Response

Ampersand Biosciences generously supported the Block Symposium-Tailoring the Immune Response at the Immunology2024 annual meeting of the american association of immunologists in Chicago, Illinois.

May 6, 2024/by Geoff Sanford

Ampersand biosciences participates in Touch a Truck Funraiser 2023

Ampersand Biosciences participated in the annual Touch a Truck Fundraiser in 2023 in Saranac Lake, NY.

September 17, 2023/by Geoff Sanford

Frontier Fact: 4 Biotech Companies

Ampersand Biosciences was written about in the Adirondack Frontier for being locally rooted and thriving as a biotechnology company in Saranac Lake.

June 19, 2023/by Geoff Sanford

Ampersand Biosciences Receives SBIR Grant 2022

Ampersand Biosciences has been awarded the SBIR Grant for 2022 for immunologic analysis of non-mammalian and underrepresented mammalian models such as hamster.

Species: Hamster
Focus: Severe infectious diseases, Influenza, SARS-CoV-2

July 14, 2022/by Geoff Sanford

Ampersand Biosciences awarded a contract by the NIAID for the development of Ferret Reagents for us in the characterization of immune responses to respiratory infections in the ferret model

Ampersand Biosciences was awarded a contract by the National Institute of Allergy and Infectious Diseases (NIAID) on July 1, 2020 until August 31, 2022 to address an urgent need to develop reagents to better understand and describe the immunologic analyses of respiratory infections in the ferret. Phase 1 will produce commercially available ferret-specific immunoreagents. Phase 2 will develop Luminex kits for quantitative multiplex analyses of innate immune mediators.

NAICS: 541714 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC: AN12 - Health R&D Services; Health Care Services; Applied Research

July 1, 2020/by Geoff Sanford

Ampersand Biosciences awarded contract for Map Analysis by the CDC

Ampersand Biosciences was awarded a contract by the CDC Office of Acquisition Services (OAS) [HHS - CDC] on May 30, 2018 until November 30, 2018 for map analysis.

NAICS: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
PSC: B504 - Special Studies/Analysis - Chemical/Biological

May 13, 2018/by Geoff Sanford

Ampersand Biosciences awarded contract for Analyte Identification Services by ACC

Ampersand Biosciences was awarded a contract by the ACC Aberdeen Proving Ground (APG) [DoD - USA - AMC - ACC] on July 20, 2017 until July 31, 2019 for analyte identification services.

NAICS: 541711 - Research And Development In Biotechnology
PSC: AN42 - Health R&D Services; Health Care - Other; Applied Research

July 20, 2017/by Geoff Sanford

Ampersand Biosciences in the News: An innovator success story

Ampersand Biosciences was featured as a news story in the NNY360 about its formation as a biomedical research and development company and it's dedication to performing contract work for medical research businesses.

December 7, 2015/by Geoff Sanford

Ampersand Biosciences in the News: Saranac Lake Loses One, Gains One in Biotech

Ampersand Biosciences was featured as a news story in the NCPR about its formation as a new biotech company that will stay in Saranac Lake.

January 23, 2015/by Geoff Sanford